Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,830 | -79,129 | -106,519 | -102,337 | -95,446 |
| Depreciation Amortization | 14,247 | 11,287 | 11,487 | 14,592 | 15,504 |
| Accounts receivable | -30,494 | -16,892 | -10,827 | 29,028 | 6,581 |
| Other Working Capital | -49,850 | -56,015 | 88,386 | 92,958 | 27,787 |
| Other Operating Activity | 63,991 | 51,663 | 44,845 | -11,166 | 15,278 |
| Operating Cash Flow | $-69,936 | $-89,086 | $27,372 | $23,075 | $-30,296 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 95,120 | 65,722 | -67,277 | -150,694 | 120,458 |
| PPE Investments | -97,318 | -34,857 | -18,446 | -2,811 | -4,964 |
| Other Investing Activity | 50 | -50 | 0 | -1,600 | 0 |
| Investing Cash Flow | $-2,148 | $30,815 | $-85,723 | $-155,105 | $115,494 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,640 | 0 | N/A | N/A | N/A |
| Debt Repayment | -875 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 8,598 | 7,949 | 319,400 | 185,008 | 4,081 |
| Other Financing Activity | 0 | -200,807 | 0 | 390 | 0 |
| Financing Cash Flow | $31,363 | $-192,858 | $319,400 | $185,398 | $4,081 |
| Beginning Cash Position | 247,796 | 498,925 | 237,876 | 184,508 | 95,229 |
| End Cash Position | 207,075 | 247,796 | 498,925 | 237,876 | 184,508 |
| Net Cash Flow | $-40,721 | $-251,129 | $261,049 | $53,368 | $89,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,936 | -89,086 | 27,372 | 23,075 | -30,296 |
| Capital Expenditure | -97,318 | -34,857 | -18,446 | -2,811 | -4,964 |
| Free Cash Flow | -167,254 | -123,943 | 8,926 | 20,264 | -35,260 |